Ibogaine

Michigan Is On The Edge Of Decriminalizing Psychedelics

Apr 5, 2022

MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program

Mar 2, 2022

Psygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility

Jan 18, 2022

MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC

Jan 4, 2022

Ibogaine Addiction Treatments & MDMA Assisted-Psychotherapy: MINDCURE & The State Of Psychedelic Therapeutics…

Nov 23, 2021

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update

Nov 15, 2021

Detroit Is The Latest City To Decriminalize Psychedelics

Nov 10, 2021

MINDCURE Provides Update on Studies and Clinical Trials

Nov 4, 2021

Ibogaine: Why This Anti-Addictive Psychedelic Could Help Treat More Than Substance Use

Sep 27, 2021

DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder

Sep 21, 2021